GUT: 非实质性TREM-2可保护肝脏免受免疫介导的肝细胞损伤

2018-12-02 MedSci MedSci原创

肝脏损伤可以通过Toll样受体(TLR)信号传导导致炎症。而在骨髓细胞2(TREM-2)上表达的触发受体调节骨髓(BM)衍生的巨噬细胞中TLR4介导的炎症,但其在肝损伤中的功能是未知的,因此有研究人员假设TREM-2对TLR信号传导具有抗炎作用并会限制肝损伤。

背景及目的
肝脏损伤可以通过Toll样受体(TLR)信号传导导致炎症。而在骨髓细胞2(TREM-2)上表达的触发受体调节骨髓(BM)衍生的巨噬细胞中TLR4介导的炎症,但其在肝损伤中的功能是未知的,因此有研究人员假设TREM-2对TLR信号传导具有抗炎作用并会限制肝损伤。

方法
研究人员在野生型和Trem-2- / -小鼠中进行急性和慢性肝损伤模型的建立,并分离来自两种基因型小鼠的原代肝细胞用于体外实验。

结果
TREM-2可以在非实质性肝细胞上表达,并在小鼠和人的肝损伤过程中诱导出现。缺乏TREM-2的小鼠在急性和四氯化碳和对乙酰氨基酚(APAP)中毒期间表现出增强的肝损伤和炎症,TREM-2缺乏与存活率恶化显着相关。BM移植实验和细胞活性氧物质测定揭示TREM-2在慢性损伤的背景下的作用取决于免疫和驻留TREM-2表达。缺乏TREM-2的原代肝巨噬细胞和肝星状细胞表现出增强的TLR4驱动的促炎反应。

结论
本项研究结果表明,通过在肝细胞损伤期间作为炎症的天然驱动因子的TREM-2是多种类型肝毒性损伤的关键调节剂。

原始出处:

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1796377, encodeId=47a01e963770b, content=<a href='/topic/show?id=9a1b1e7916c' target=_blank style='color:#2F92EE;'>#TREM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17791, encryptionId=9a1b1e7916c, topicName=TREM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 16 10:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752251, encodeId=58f81e5225123, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Wed Sep 11 11:53:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863403, encodeId=8ad0186340370, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sat Feb 02 09:53:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397675, encodeId=f016139e67524, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Dec 04 12:53:00 CST 2018, time=2018-12-04, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1796377, encodeId=47a01e963770b, content=<a href='/topic/show?id=9a1b1e7916c' target=_blank style='color:#2F92EE;'>#TREM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17791, encryptionId=9a1b1e7916c, topicName=TREM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 16 10:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752251, encodeId=58f81e5225123, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Wed Sep 11 11:53:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863403, encodeId=8ad0186340370, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sat Feb 02 09:53:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397675, encodeId=f016139e67524, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Dec 04 12:53:00 CST 2018, time=2018-12-04, status=1, ipAttribution=)]
    2019-09-11 tongyongming
  3. [GetPortalCommentsPageByObjectIdResponse(id=1796377, encodeId=47a01e963770b, content=<a href='/topic/show?id=9a1b1e7916c' target=_blank style='color:#2F92EE;'>#TREM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17791, encryptionId=9a1b1e7916c, topicName=TREM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 16 10:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752251, encodeId=58f81e5225123, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Wed Sep 11 11:53:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863403, encodeId=8ad0186340370, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sat Feb 02 09:53:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397675, encodeId=f016139e67524, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Dec 04 12:53:00 CST 2018, time=2018-12-04, status=1, ipAttribution=)]
    2019-02-02 xjy02
  4. [GetPortalCommentsPageByObjectIdResponse(id=1796377, encodeId=47a01e963770b, content=<a href='/topic/show?id=9a1b1e7916c' target=_blank style='color:#2F92EE;'>#TREM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17791, encryptionId=9a1b1e7916c, topicName=TREM)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Sun Jun 16 10:53:00 CST 2019, time=2019-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1752251, encodeId=58f81e5225123, content=<a href='/topic/show?id=28a915303ec' target=_blank style='color:#2F92EE;'>#REM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15303, encryptionId=28a915303ec, topicName=REM)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=78bc36479935, createdName=tongyongming, createdTime=Wed Sep 11 11:53:00 CST 2019, time=2019-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1863403, encodeId=8ad0186340370, content=<a href='/topic/show?id=c0b68135561' target=_blank style='color:#2F92EE;'>#肝细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=81355, encryptionId=c0b68135561, topicName=肝细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d59291, createdName=xjy02, createdTime=Sat Feb 02 09:53:00 CST 2019, time=2019-02-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1397675, encodeId=f016139e67524, content=<a href='/topic/show?id=8bee565436d' target=_blank style='color:#2F92EE;'>#损伤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=56543, encryptionId=8bee565436d, topicName=损伤)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eoNX3lUOlDKGBUEPNwZx0nibmdcFyeibnX4WMhUSCU2REpGRWtSmnT2CCs0dA5waxvJknYDxwtYnIcQ/132, createdBy=294e2500218, createdName=ms3046638856685384, createdTime=Tue Dec 04 12:53:00 CST 2018, time=2018-12-04, status=1, ipAttribution=)]

相关资讯

J Gastroenterology:高水平的血清Mac-2结合蛋白糖基化异构体(M2BPGi)可以预测用核苷酸类似物治疗的乙型肝炎患者肝细胞癌的发展

核苷酸类似物(NA)可降低肝细胞癌(HCC)发生的风险,但不能完全阻止其发展。本项研究旨在探究预测核苷类似物治疗乙肝中预测结局的因子。

J Gastroenterology:肝细胞癌是日本2型糖尿病患者中癌症相关死亡的主要原因

之前有一项关于日本2型糖尿病(T2D)患者肝损伤原因的横断面研究在J Gastroenterology上发表了,现在,那篇文章的作者又再一次从原本的样本中研究评估了2013年JG患者随访期间的总体和特异性死亡风险。

GUT : 肠道微生物组分分析可以作为早期肝细胞癌的靶向治疗的非侵入性生物标志物

本项研究希望能探明肝细胞癌(HCC)患者肠道微生物组的特征,并借此评价微生物组作为HCC非侵入性生物标志物的潜力。

AP&T: 直接作用抗病毒药物(DAA)在治疗肝细胞癌的丙型肝炎病毒感染肝硬化患者中效果优良

目前直接作用抗病毒(DAA)疗法对肝细胞癌(HCC)病史患者的疗效尚不清楚。因此本项研究的目的是前瞻性地评估了以前治疗过的HCC是否影响肝硬化患者的DAA疗效。

J Hepatology: 一种可以预测肝切除术后肝细胞癌发生率的模型

肝切除术是早期肝细胞癌(HCC)患者最广泛使用治愈性治疗方法。然而,2年内复发的患者占30-50%,而且是导致死亡的主要原因。在本文中,研究人员基于临床数据构建了预测模型来评估早期复发的风险。

Clinical and Translational Gastroenterolog:一种用于预测肝细胞癌的新型糖标记物

紫藤(Wisteria floribunda)凝集素阳性人Mac-2结合蛋白(WFA-M2BP)是一种糖标记物。研究人员对一些肝癌高危患者进行长期随访,重复测定他们体内血清WFA-M2BP水平,并检查其与丙型肝炎病毒(HCV)相关的肝细胞癌(HCC)的短期和长期关联。